These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24188871)

  • 21. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
    Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome.
    Mansour A; Hashemi Taheri AP; Moradi B; Mohajeri-Tehrani MR; Qorbani M; Ghorbani Pashakolaee S; Sanginabadi M; Sajjadi-Jazi SM
    BMC Endocr Disord; 2022 Dec; 22(1):298. PubMed ID: 36456925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound examination of polycystic ovaries: is it worth counting the follicles?
    Jonard S; Robert Y; Cortet-Rudelli C; Pigny P; Decanter C; Dewailly D
    Hum Reprod; 2003 Mar; 18(3):598-603. PubMed ID: 12615832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of counting follicles in diagnosis of polycystic ovary syndrome by the three-dimensional ultrasound imaging with sonography based automated volume calculation method].
    He LR; Zhou LX; Pan RK; Zhang X
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):350-4. PubMed ID: 21733371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled trial of a lifestyle intervention with longitudinal follow-up on ovarian dysmorphology in women with polycystic ovary syndrome.
    Kazemi M; Pierson RA; McBreairty LE; Chilibeck PD; Zello GA; Chizen DR
    Clin Endocrinol (Oxf); 2020 Jun; 92(6):525-535. PubMed ID: 32092167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian volume is more closely related to the different manifestations of polycystic ovary syndrome than follicle number per ovary.
    Afrine S; Haque JA; Morshed MS; Banu H; Hossain A; Hasanat MA
    Clin Exp Reprod Med; 2023 Sep; 50(3):200-205. PubMed ID: 37643834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome.
    van Santbrink EJ; Hop WC; Fauser BC
    Fertil Steril; 1997 Mar; 67(3):452-8. PubMed ID: 9091329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome.
    Dewailly D; Catteau-Jonard S; Reyss AC; Maunoury-Lefebvre C; Poncelet E; Pigny P
    Hum Reprod; 2007 Jun; 22(6):1562-6. PubMed ID: 17449514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study.
    Ahmad AK; Kao CN; Quinn M; Lenhart N; Rosen M; Cedars MI; Huddleston H
    Fertil Steril; 2018 Mar; 109(3):526-531. PubMed ID: 29428308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk.
    Quinn MM; Kao CN; Ahmad A; Lenhart N; Shinkai K; Cedars MI; Huddleston HG
    Fertil Steril; 2016 Oct; 106(5):1244-1251. PubMed ID: 27445197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.
    Alsamarai S; Adams JM; Murphy MK; Post MD; Hayden DL; Hall JE; Welt CK
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4961-70. PubMed ID: 19846740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Performance of Ovarian Morphology on Ultrasonography across Anovulatory Conditions-Impact of Body Mass Index.
    Vanden Brink H; Jarrett BY; Pereira N; Spandorfer SD; Hoeger KM; Lujan ME
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries.
    Lujan ME; Chizen DR; Peppin AK; Kriegler S; Leswick DA; Bloski TG; Pierson RA
    Reprod Biol Endocrinol; 2008 Jul; 6():30. PubMed ID: 18638401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ratio of ovarian stroma and total ovarian area by ultrasound in prediction of hyperandrogenemia in reproductive-aged Thai women with polycystic ovary syndrome: a diagnostic test.
    Leerasiri P; Wongwananuruk T; Rattanachaiyanont M; Indhavivadhana S; Techatraisak K; Angsuwathana S
    J Obstet Gynaecol Res; 2015 Feb; 41(2):248-53. PubMed ID: 25227757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic value of ovarian morphology by ultrasonography in pubertal polycystic ovary syndrome].
    Chen YX; Yang DZ; Li L; Chen XL; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):586-9. PubMed ID: 17983511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of ovarian vascularization in the polycystic ovary by three-dimensional power Doppler ultrasonography.
    Pascual MA; Graupera B; Hereter L; Tresserra F; Rodriguez I; Alcázar JL
    Gynecol Endocrinol; 2008 Nov; 24(11):631-6. PubMed ID: 19031220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.